Histiocytosis clinical trials

Explore recruiting histiocytosis clinical trials.

Recruiting histiocytosis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Histiocytosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Determination Of Molecular Status And Benefit Of Use Fludeoxyglucose (18F-FDG) In PET/CT imagining In Juvenile Patients With Histiocytosis

Poland

Therapeutic use (Phase IV) EU CTIS Study details

LCH-IV International Collaborative Treatment Protocol for Children and Adolescents with Langerhans Cell Histiocytosis

Czechia, Netherlands, Italy, Austria, Norway, Spain +6 more

Phase II and Phase III (Integrated) EU CTIS Study details

Optimalization Of The Time And Dosage Of Vemurafenib In BRAF Positive Juvenile Patients With Refractory Histiocytosis

Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Optimalization Of The Time And Dosage Of Trametinib In BRAF Negative Juvenile Patients With Refractory Histiocytosis Or After Failure Of Vemurafenib Treatment.

Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Histiocytosis trials by city

Histiocytosis in Toronto Histiocytosis in Vancouver Histiocytosis in Montreal Histiocytosis in Calgary Histiocytosis in Edmonton Histiocytosis in Ottawa Histiocytosis in Winnipeg Histiocytosis in Quebec City Histiocytosis in Hamilton Histiocytosis in Kitchener Histiocytosis in London Histiocytosis in Halifax Histiocytosis in New York Histiocytosis in Los Angeles Histiocytosis in Chicago Histiocytosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease